Sakar Healthcare Ltd.

354.45 -14.15 ▼-3.8%

25 April 2024, 03:50:30 PM
Volume: 34,181

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sakarhealthcare.com
Market Cap 770.93 Cr.
Enterprise Value(EV) 863.62 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 5.73 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 61.81 Trailing Twelve Months Ending 2023-12
Industry PE 41.30 Trailing Twelve Months Ending 2023-12
Book Value / Share 118.28 Trailing Twelve Months Ending 2023-12
Price to Book Value 3.00 Calculated using Price: 354.45
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 2.17 Cr. 21,749,910 Shares
FaceValue 10
About Sakar Healthcare Ltd.
The company is an Indian pharmaceutical company engaged in the manufacturing and marketing of its own pharmaceutical formulations for domestic and international markets. Its Product domestic sales are generally exported by third party. It also undertakes contract manufacturing of formulations for pharmaceutical companies based in India. It manufactures and markets pharmaceutical formulations relating to analgesics, antielminthics, anti coagulants, anti malarial, anti spasmodics, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.

Sakar Healthcare Ltd. Delivery

Delivered Qty
Traded Qty

Sakar Healthcare Ltd. Performance

1 Day
-3.84%
1 Week
-4.78%
1 Month
-3.08%
3 Month
-19.82%
6 Month
+1.16%
1 Year
+65.55%
2 Year
+151.20%
5 Year
+457.31%
10 Year

Sakar Healthcare Ltd. Fundamental Ratios

4 years 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 11.83 11.88 13.44 8.48
Return on Capital Employed (%) 14.79 13.16 12.09 8.95
Return on Assets (%) 8.36 7.3 6.81 4.22

Sakar Healthcare Ltd. Balance Sheet

Particulars 5 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 81 98 127 173 237
Non Curr. Liab. 20 46 94 109 74
Curr. Liab. 14 33 47 54 47
Minority Int.
Equity & Liab. 115 178 268 336 357
Non Curr. Assets 93 144 218 280 300
Curr. Assets 22 34 50 56 57
Misc. Exp. not W/O
Total Assets 115 178 268 336 357

Sakar Healthcare Ltd. Profit and Loss

Particulars 5 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 83 95 128 133 151
Other Income 2 1 2 5 4
Total Income 85 96 130 138 155
Total Expenditure -63 -72 -99 -100 -116
PBIDT 22 24 32 38 39
Interest -2 -2 -3 -6 -8
Depreciation -7 -8 -10 -15 -17
Taxation -3 -3 -4 -4 -3
Exceptional Items 0
PAT 10 11 15 13 12
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 10 11 15 13 12
Adjusted EPS 6 7 9 7 6

Sakar Healthcare Ltd. Cash Flow

Particulars 4 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 19 15 36 33
Cash Fr. Inv. -22 -47 -90 -74
Cash Fr. Finan. 3 32 55 41
Net Change 0 0 0 0
Cash & Cash Eqvt 0 0 0 0

Sakar Healthcare Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 67.54 67.54 62.10 62.10 60.72 60.72 54.15 53.15 53.15
Public 32.46 32.46 37.90 37.90 39.28 39.28 45.85 46.85 46.85
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Sakar Healthcare Ltd. Announcements

Fri, 12 Apr 2024
Disclosure under SEBI Takeover Regulations
Sanjay S. Shah has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Fri, 05 Apr 2024
Updates
Sakar Healthcare Limited has informed the Exchange regarding 'Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter Ended 31st March 2024'.
Fri, 29 Mar 2024
Trading Window-XBRL
SAKAR HEALTHCARE LIMITED has informed the Exchange about Closure of Trading Window

Sakar Healthcare Ltd. Technical Scans

Wed, 24 Apr 2024
Closing Above Previous High Closing Above Previous High
Making Higher Highs for 2 Days Making Higher Highs for 2 Days
High Decrease in 3 Months High Decrease in 3 Months
High Increase in 1 Year High Increase in 1 Year
High Increase in 2 Years High Increase in 2 Years

Sakar Healthcare Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 360,140.18 1,520.15 +2.3%
Cipla Ltd. 112,292.49 1,406.20 +0.6%
Divi's Laboratories Ltd. 101,276.26 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. 99,314.42 6,218.75 +4.5%
Mankind Pharma Ltd. 95,586.41 2,398.55 +0.0%
Zydus Lifesciences Ltd. 93,730.70 951.25 +1.9%
Torrent Pharmaceuticals Ltd. 90,650.92 2,694.30 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.44 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 30.28 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 73.23 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.00 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-12 55.35 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.52 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.68 2,694.30 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.77 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 4.34 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 7.77 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-12 10.76 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.97 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.68 2,694.30 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,694.30 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,694.30 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,694.30 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,694.30 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,694.30 +0.3%

Sakar Healthcare Ltd. FAQ's

What is Sakar Healthcare share price?

Can I buy Sakar Healthcare shares now?

What is the Market Cap of Sakar Healthcare?

What are the key metrics to analyse Sakar Healthcare?

What is the 52 Week High and Low of Sakar Healthcare?

What is the trend of Sakar Healthcare share price?